(WASHINGTON) #Coronavirus FDA Press Release Report: #COVID19 is now the No. 3 cause of death in the U.S. and FDA has issued an emergency use authorisation for a saliva test that can easily detect the virus: The technology is being described as a potential game-changer that many have been waiting waited for as its quick, non-invasive way #AceHealthDesk report

#AceHealthReport – Aug.18: is what many have been waiting for — a quick, non-invasive and inexpensive way to find out if they’ve been infected with the #coronavirus: The newest saliva #COVID19 test to get the nod from the FDA was developed by researchers at Yale University and funded by the National Basketball Association, which also uses the test that’s called SalivaDirect: “It doesn’t need the same re-agents and swabs that have been the limiting steps to create testing at scale in this country. It really could be a game-changer if we can deploy it,” said epidemiologist Dr. Abdul El-Sayed…………..The test was developed for people who don’t have symptoms………..It’s thought to be about 90% as accurate as other tests using nose and throat swabs, the developers expect up to 200,000 samples a day could be processed:

#Coronavirus Report: FDA Issues an Emergency Use Authorisation ‘ for a ‘ saliva test ‘ that is quick, non-invasive and could be a game-changer

Coronavirus (COVID-19) Update: Daily Roundup August 17, 2020

August 17, 2020

FDA News Release

For Immediate Release:

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

  • The FDA issued Yale School of Public Health an emergency use authorization (EUA) for its SalivaDirect COVID-19 diagnostic test, which uses a new method of processing saliva samples when testing for COVID-19. This molecular test is for the qualitative detection of nucleic acid from SARS-CoV-2 in saliva collected without preservatives in a sterile container from individuals suspected of COVID-19 by their healthcare provider. SalivaDirect does not require any special type of swab or collection device – a saliva sample can be collected in any sterile container. It is also unique because it does not require a separate nucleic acid extraction step. This is significant because the extraction kits used for this step in other tests have been prone to shortages in the past.
  • As part of the FDA’s effort to protect consumers, the agency issued a joint warning letter with the Federal Trade Commission to SilveryGuy, a company that participates in the Amazon Associates program, for selling fraudulent COVID-19 related products. As an Amazon associate, the company earns commissions by promoting the sale of Colloidal Silver products on the company’s website, with misleading claims that the product can mitigate, prevent, treat, diagnose, or cure COVID-19 in people. Currently, there are no FDA-approved products to prevent or treat COVID-19. Consumers concerned about COVID-19 should consult with their health care provider.
  • Testing updates:
    • To date, the FDA has currently authorized 214 tests under EUAs; these include 175 molecular tests, 37 antibody tests, and 2 antigen tests.

#AceHealthDesk report ……………Published: Aug.18: 2020:

Editor says #AceNewsDesk reports by https://t.me/acenewsdaily and all our posts, also links can be found at here for Twitter and Live Feeds https://acenewsroom.wordpress.com/ and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com